ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZYME ZYMEWORKS INC (US)

Trading 01-10 14:23:35 EST

13.00

-1.13

-8.00%

High13.94	Low12.89	Vol435.86K
Open13.80	D1 Closing14.13	Amplitude7.43%
Mkt Cap895.41M	Tradable Cap520.10M	Total Shares68.88M
T/O5.73M	T/O Rate1.09%	Tradable Shares40.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ZYME","market":"US","secType":"STK","nameCN":"ZYMEWORKS INC (US)","latestPrice":13,"timestamp":1736536989801,"preClose":14.13,"halted":0,"volume":435856,"delay":0,"floatShares":40008027,"shares":68877526,"eps":-1.517898,"marketStatus":"Trading","change":-1.13,"latestTime":"01-10 14:23:35 EST","open":13.8,"high":13.94,"low":12.89,"amount":5730685.6831519995,"amplitude":0.07431,"askPrice":13.04,"askSize":380,"bidPrice":12.98,"bidSize":210,"shortable":3,"etf":0,"ttmEps":-1.517898,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1736542800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1493352000000,"exchange":"NASDAQ","adjPreClose":14.13,"preHourTrading":{"tag":"盘前","latestPrice":14.45,"preClose":14.13,"latestTime":"09:24 EST","volume":427,"amount":6165.899642,"timestamp":1736519098016},"postHourTrading":{"tag":"盘后","latestPrice":14.13,"preClose":14.13,"latestTime":"16:20 EST","volume":16873,"amount":238417.77,"timestamp":1736371200986},"volumeRatio":1.043761,"impliedVol":1.3397,"impliedVolPercentile":0.9124},"requestUrl":"/m/hq/s/ZYME/tweets","defaultTab":"tweets","newsList":[{"id":"2502014952","title":"Zymeworks (ZYME) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2502014952","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502014952?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:06","pubTimestamp":1736427976,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of $28.00. The co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zymeworks-zyme-receives-a-buy-from-stifel-nicolaus-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zymeworks-zyme-receives-a-buy-from-stifel-nicolaus-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4139","BK4127","ZYME"],"gpt_icon":0},{"id":"2502089383","title":"Zymeworks Sees Current Cash Resources, Expected Payments to Support Operations Into H2 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2502089383","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502089383?lang=en_us&edition=fundamental","pubTime":"2025-01-09 06:04","pubTimestamp":1736373896,"startTime":"0","endTime":"0","summary":"Zymeworks  said Wednesday it exited 2024 with around $324 million in cash that should support its operations at projected levels into H2 2027, when combined with anticipated milestone payments.The $324 million cash, cash equivalent reserve on Dec. 31 does not include a $25 milestone payment due in the current quarter from Jazz Pharmaceuticals  that was triggered by approval in the US of Ziihera bispecific antibody treatment for HER2-positive biliary tract cancer.Zymeworks also said the company is well-positioned for additional progress with its drug pipeline to potential treat various autoimmune and inflammatory diseases as well as hematological cancers.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4533","LU0109394709.USD","LU0320765992.SGD","BK4007","BK4532","LU0889565916.HKD","JAZZ","ZYME"],"gpt_icon":0},{"id":"2502887600","title":"Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2502887600","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502887600?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:05","pubTimestamp":1736370300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA7CSXGB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"gpt_icon":0},{"id":"2502868083","title":"Zymeworks Inc - Ind Applications for ZW209 and ZW1528 Expected in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2502868083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502868083?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:05","pubTimestamp":1736370300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA7CSXGB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"gpt_icon":0},{"id":"2502083850","title":"Zymeworks Inc - Ind Applications for ZW220 and ZW251 in Solid Tumors Expected in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083850?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:05","pubTimestamp":1736370300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA7CSXGB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"gpt_icon":0},{"id":"2500121429","title":"Landsea Homes, LandBridge, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2500121429","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500121429?lang=en_us&edition=fundamental","pubTime":"2025-01-04 05:31","pubTimestamp":1735939860,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Dec. 26, 2024, through Jan. 1, 2025. Source: VerityData. Landsea Homes  Mill Road Capital III disclosed a new position in the residential real estate development company of 1,818,281 shares. Mill Road Capital reported that it purchased 853,500 Landsea Homes shares from Nov. 6 through Dec. 23, 2024, at per share prices ranging from $10.25 to $12.50.Following the latest purchases, Mill Road Capital owns 5% of Landsea Homes' outstanding stock, placing it at the 5% threshold that requires it to disclose further Landsea Homes purchases or sales. Shares of Landsea Homes lost nearly a third of their value in 2024.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","FOA","BK4139","BK4211","BK4213","RMBL","ZYME","LB","ISBC","BK4233","BK4229","BK4214","BK4088","LSEA","BK4122"],"gpt_icon":0},{"id":"2491613908","title":"BUZZ-Zymeworks jumps after JPM upgrades stock to 'overweight'","url":"https://stock-news.laohu8.com/highlight/detail?id=2491613908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491613908?lang=en_us&edition=fundamental","pubTime":"2024-12-16 23:44","pubTimestamp":1734363897,"startTime":"0","endTime":"0","summary":"BUZZ-Zymeworks jumps after JPM upgrades stock to 'overweight'** Cancer therapy developer Zymeworks' ZYME.O shares up as much as 10.6% to $13.91** Brokerage J.P.Morgan upgrades company's shares to \"overweight\" from \"neutral\", raises PT by $6 to $18** Recent R&D day event has brokerage more confident in company's oncology and autoimmune diseases pipeline, with two distinct TCE, ADC cancer therapies progressing in the clinics - JPM** Company's cancer drug Zani provides \"solid support\" to stock valuation - brokerage** JPM believes 2025 is the year to pay attention and could begin to see one or more of company's \"5x5\" pipeline plan succeeding in clinics** Zymeworks' internal portfolio is largely underappreciated at this level as it begins to take shape as a true \"multiple shots on goal\" story with attractive upside potential - brokerage** Brokerage Jefferies also raises PT on company's shares by $2 to $24** 6 of 8 brokerages rate the stock \"buy\" or higher, and 2 \"hold\"; median PT $18.75 - L","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4N3NH14Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME"],"gpt_icon":0},{"id":"2491693513","title":"JPMorgan Upgrades Zymeworks to Overweight From Neutral, Adjusts Price Target to $18 From $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2491693513","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491693513?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:58","pubTimestamp":1734353927,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) has an average rating of overweight and mean price target of $20.19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZYME"],"gpt_icon":0},{"id":"2491653849","title":"Zymeworks Inc : Jefferies Raises Target Price to $24 From $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2491653849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491653849?lang=en_us&edition=fundamental","pubTime":"2024-12-16 15:34","pubTimestamp":1734334444,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH0A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139"],"gpt_icon":0},{"id":"2491463722","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2491463722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491463722?lang=en_us&edition=fundamental","pubTime":"2024-12-16 14:30","pubTimestamp":1734330657,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research Report), Zymew...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-zymeworks-zyme-and-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-zymeworks-zyme-and-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4585","HIMS","BK4505","AXSM","BK4007","BK4139","ZYME","HCSG","BK4137"],"gpt_icon":0},{"id":"2491394686","title":"Zymeworks Inc : JP Morgan Raises to Overweight From Neutral; Raises Target Price to $18 From $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2491394686","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491394686?lang=en_us&edition=fundamental","pubTime":"2024-12-16 13:25","pubTimestamp":1734326727,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NE1F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"gpt_icon":0},{"id":"2491142893","title":"U.S. RESEARCH ROUNDUP-Amazon, Broadcom, Exxon Mobil","url":"https://stock-news.laohu8.com/highlight/detail?id=2491142893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491142893?lang=en_us&edition=fundamental","pubTime":"2024-12-13 15:08","pubTimestamp":1734073722,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amazon, Broadcom, Exxon MobilDec 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, Broadc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nL4N3NE0FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923621640.USD","LU2108987350.USD","LU0965509101.SGD","LU1267930573.SGD","BK4575","LU1430597077.USD","LU1720051108.HKD","SG9999001440.SGD","TOL","SRFM","LU0795875086.SGD","AMZN","ZYME","LU0456854461.SGD","LU0965509010.AUD","LU2023250330.USD","GLPI","MTH","LU0130103400.USD","LU0878866978.SGD","SGXZ23171101.USD","LU1150488135.SGD","LU1496350502.SGD","LU0348723411.USD","IE00BZ9MQY76.HKD","CHRW","LU0942090050.USD","LU1582987324.SGD","SAFE","AES","LU0289961442.SGD","MKSI","SG9999015358.SGD","USAW.SI","WM","BK4131","DHI","FISI","IE00B3CCJ963.GBP","LU2236285917.USD","LU1435385759.SGD","CIEN","XOM","LU1201861165.SGD","BK4512","AVGO","CCS","EDIT","BOLD","LU0107464264.USD"],"gpt_icon":1},{"id":"2490381555","title":"Zymeworks Advances Oncology and Expands Therapeutic Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2490381555","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490381555?lang=en_us&edition=fundamental","pubTime":"2024-12-12 22:08","pubTimestamp":1734012493,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) has released an update. Zymeworks is making significant strides in its clinical pipeline, with plans to advance five drug candidat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zymeworks-advances-oncology-and-expands-therapeutic-reach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zymeworks-advances-oncology-and-expands-therapeutic-reach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"gpt_icon":0},{"id":"2485666268","title":"PRESS DIGEST-Canada - Nov 22","url":"https://stock-news.laohu8.com/highlight/detail?id=2485666268","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485666268?lang=en_us&edition=fundamental","pubTime":"2024-11-22 21:26","pubTimestamp":1732281964,"startTime":"0","endTime":"0","summary":"PRESS DIGEST-Canada - Nov 22Nov 22 (Reuters) - The following are the top stories from a selected Canadian newspaper. Reuters has not verified these stories and does not vouch for their accuracy.THE GL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4N3MT0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","ZYME","JAZZ","BK4532","LU0109394709.USD","LU0889565916.HKD","BK4139","BK4007","LU0320765992.SGD"],"gpt_icon":0},{"id":"2485625164","title":"Zymeworks Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2485625164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485625164?lang=en_us&edition=fundamental","pubTime":"2024-11-22 20:05","pubTimestamp":1732277100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZYME/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 22, 2024 07:05 ET (12:05 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME"],"gpt_icon":0},{"id":"2485929784","title":"Zymeworks Shares up 2.8% After FDA Approves Co, Jazz Pharma's Biliary Tract Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2485929784","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485929784?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:32","pubTimestamp":1732199571,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL4N3MS14M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139"],"gpt_icon":0},{"id":"2485963492","title":"Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK","url":"https://stock-news.laohu8.com/highlight/detail?id=2485963492","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485963492?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:30","pubTimestamp":1732199400,"startTime":"0","endTime":"0","summary":"Shares of Zymeworks rose early Thursday after the cancer therapy it is developing with Jazz Pharmaceuticals received accelerated regulatory approval for treating forms of biliary tract cancer.Zymeworks' stock was up 8.3% to $15.75 in pre-market trading. Shares are up about 40% this year as of Wednesday's close.The U.S. Food and Drug Administration granted Ziihera, an antibody treatment, accelerated approval for injection for intravenous use in treating adults with certain forms of biliary tract cancer.Zymeworks first developed the molecule, and in 2022 entered a license and collaboration deal with Jazz for exclusive development and commercialization rights to the compound in most countries. Under the licensing deal, Zymeworks has earned a milestone payment of $25 million based on FDA approval of Ziihera in BTC.Jazz shares were up about 2.3% in pre-market trading.BeiGene has the compound's license in Asia Pacific territories.Zymeworks said Ziihera was the first candidate in its pipeline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGNE","BK4526","LU0109394709.USD","LU0889565916.HKD","JAZZ","ZYME","BK4139","BK4588","BK4535","BK4505","BK4007","BK4548","BK4585","LU0320765992.SGD","BK4533","BK4532","BK4504"],"gpt_icon":0},{"id":"2485649161","title":"Zymeworks Inc : Leerink Partners Raises Target Price to $26 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2485649161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485649161?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:55","pubTimestamp":1732197319,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nFWN3MS0RQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"gpt_icon":0},{"id":"2485498056","title":"Zymeworks to Showcase Innovations at Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2485498056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485498056?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:44","pubTimestamp":1732193085,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) has released an update. Zymeworks Inc. is set to engage with investors at several high-profile healthcare conferences, showcasing ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zymeworks-to-showcase-innovations-at-investor-conferences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zymeworks-to-showcase-innovations-at-investor-conferences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"gpt_icon":0},{"id":"2485498703","title":"Zymeworks Secures FDA Approval for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2485498703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485498703?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:43","pubTimestamp":1732193002,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) has released an update. Zymeworks has achieved a significant milestone with the FDA’s accelerated approval of Ziihera, a dual HER2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zymeworks-secures-fda-approval-for-ziihera?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zymeworks-secures-fda-approval-for-ziihera?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zymeworks.com","stockEarnings":[{"period":"1week","weight":-0.0348},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.4032},{"period":"1year","weight":0.2287},{"period":"ytd","weight":-0.0348}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.031452},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.066197},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.021688},{"month":4,"riseRate":0.571429,"avgChangeRate":0.031631},{"month":5,"riseRate":0.375,"avgChangeRate":0.035333},{"month":6,"riseRate":0.5,"avgChangeRate":-0.064157},{"month":7,"riseRate":0.375,"avgChangeRate":-0.034914},{"month":8,"riseRate":0.875,"avgChangeRate":0.094755},{"month":9,"riseRate":0.375,"avgChangeRate":0.024256},{"month":10,"riseRate":0.625,"avgChangeRate":0.033924},{"month":11,"riseRate":0.75,"avgChangeRate":0.102347},{"month":12,"riseRate":0.625,"avgChangeRate":0.007334}],"exchange":"NASDAQ","name":"ZYMEWORKS INC (US)","nameEN":"ZYMEWORKS INC (US)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ZYMEWORKS INC (US),ZYME,ZYMEWORKS INC (US)股票,ZYMEWORKS INC (US)股票老虎,ZYMEWORKS INC (US)股票老虎国际,ZYMEWORKS INC (US)行情,ZYMEWORKS INC (US)股票行情,ZYMEWORKS INC (US)股价,ZYMEWORKS INC (US)股市,ZYMEWORKS INC (US)股票价格,ZYMEWORKS INC (US)股票交易,ZYMEWORKS INC (US)股票购买,ZYMEWORKS INC (US)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}